Potential of immobilized artificial membranes for predicting drug penetration across the blood-brain barrier

被引:111
作者
Reichel, A [1 ]
Begley, DJ [1 ]
机构
[1] Kings Coll London, Dept Physiol, Div Biomed Sci, London WC2R 2LS, England
关键词
blood-brain barrier (BBB); drug transport; prediction of brain uptake; immobilized artificial membrane (IAM); HPLC;
D O I
10.1023/A:1011904311149
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The present study evaluates immobilized artificial membrane (IAM) chromatography for predicting drug permeability across the blood-brain barrier (BBB) and outlines the potential and limitations of IAMs as a predictive tool by comparison with conventional methods based on octanol/water partitioning and octadecylsilane (ODS)-HPLC. Methods. IAM- and ODS-HPLC capacity factors were determined in order to derive the hydrophobic indices log k(IAM) and log k(W) for two sets of compounds ranging from very lipid soluble (steroids) to more hydrophilic agents (biogenic amines). The uptake of the compounds across the in vivo BBB expressed as brain uptake index (BUI) has been correlated with these HPLC capacity factors as well as octanol/water partition (ClogP) and distribution coefficients (log D(7.4)). Results. For both test groups log k(IAM) correlates significantly with the respective log BUI of the drug (r(2) = 0.729 and 0.747, p < 0.05), whereas with log k(W) log D(7.4) and ClogP there is only a correlation for the group of steroids (r(2) = 0.789, 0.659 and 0.809, p < 0.05) but not for the group of biogenic amines. There is a good correlation between log k(IAM) and log k(W). ClogP or log D(7.4) for the group of steroids (r(2) = 0.935, 0.867 and 0.974, p < 0.01) but not for the biogenic amines. Conclusions. All physico-chemical descriptors examined in this study equally well describe brain uptake of lipophilic compounds, while log k(IAM) is superior over log D(7.4), ClogP and log k(W) when polar and ionizable compounds are included. The predictive value of IAMs combined with the power of HPLC holds thus great promise for the selection process of drug candidates with high brain penetration.
引用
收藏
页码:1270 / 1274
页数:5
相关论文
共 26 条
[1]   Transporting therapeutics across the blood-brain barrier [J].
Abbott, NJ ;
Romero, IA .
MOLECULAR MEDICINE TODAY, 1996, 2 (03) :106-113
[2]   Determination of solute lipophilicity, as log P(octanol) and log P(alkane) using poly(styrene-divinylbenzene) and immobilised artificial membrane stationary phases in reversed-phase high-performance liquid chromatography [J].
Abraham, MH ;
Chadha, HS ;
Leitao, ARE ;
Mitchell, RC ;
Lambert, WJ ;
Kaliszan, R ;
Nasal, A ;
Haber, P .
JOURNAL OF CHROMATOGRAPHY A, 1997, 766 (1-2) :35-47
[3]  
ABRAHAM MH, 1996, LIPOPHILICITY DRUG A, P311
[4]  
ALVAREZ FM, 1993, MOL INTERACTIONS BIO, P151
[5]  
[Anonymous], LIPOPHILICITY DRUG A
[6]   The use of the intestinal epithelial cell culture model, Caco-2, in pharmaceutical development [J].
Bailey, CA ;
Bryla, P ;
Malick, AW .
ADVANCED DRUG DELIVERY REVIEWS, 1996, 22 (1-2) :85-103
[7]   Predicting blood-brain transport of drugs: A computational approach [J].
Basak, SC ;
Gute, BD ;
Drewes, LR .
PHARMACEUTICAL RESEARCH, 1996, 13 (05) :775-778
[8]  
BENISTANT C, 1995, J LIPID RES, V36, P2311
[9]   THE BLOOD-BRAIN-BARRIER [J].
BRADBURY, MWB .
EXPERIMENTAL PHYSIOLOGY, 1993, 78 (04) :453-472
[10]  
CORNFORD EM, 1982, CELL PHYSL, V12, pC161